Systolic Dysfunction
16
2
3
6
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
12.5%
2 terminated out of 16 trials
75.0%
-11.5% vs benchmark
13%
2 trials in Phase 3/4
17%
1 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (16)
RHYthm and Myocardial Function Relationship Evaluation in Heart Diseases
Optimised MultiSite Pacing Vector Study
Cardiac Contractility Modulation in Chagas Heart Disease
Aerobic Exercise is Cardio-protective in Hemato-oncological Disease and New-onset Chemotherapy
Prevention of Age-associated Cardiac and Vascular Dysfunction Using Avmacol ES
Tumor Necrosis Factor-alpha Levels and Cardiac Functions in Type 1 Diabetes Mellitus
Sex Related Differences in Cardiac Function
How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Prevalence of Hypovolemia and Heart Failure in Non-cardiac Surgery
Bisoprolol Administration to Prevent Anthracycline-induced Cardiotoxicity
A Pilot Study of Spinal Cord Stimulation in Heart Failure Patients With Depressed Left Ventricular Function
Safety and Efficacy Study of HGP1207 in Patients With Pulmonary Hypertension
Improving Heart Failure Care in Minority Communities
Association of PICP Serum Marker in Patients With LVSD
Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients
Effect of Post Discharge Follow-up on Readmission Rates for Congestive Heart Failure Patients